BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11154906)

  • 1. Development of an enteric coating formulation and process for tablets primarily composed of a highly water-soluble, organic acid.
    Crotts G; Sheth A; Twist J; Ghebre-Sellassie I
    Eur J Pharm Biopharm; 2001 Jan; 51(1):71-6. PubMed ID: 11154906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
    Varum FJ; Hatton GB; Freire AC; Basit AW
    Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and stability evaluation of enteric coated Diclofenac sodium tablets using Sureteric.
    Zaid AN
    Pak J Pharm Sci; 2012 Jan; 25(1):59-64. PubMed ID: 22186310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of enteric coated tablets of hot-melt extruded lansoprazole.
    Alsulays BB; Kulkarni V; Alshehri SM; Almutairy BK; Ashour EA; Morott JT; Alshetaili AS; Park JB; Tiwari RV; Repka MA
    Drug Dev Ind Pharm; 2017 May; 43(5):789-796. PubMed ID: 27486807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
    Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
    Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
    Lee BJ; Ryu SG; Cui JH
    Int J Pharm; 1999 Oct; 188(1):71-80. PubMed ID: 10528084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of pantoprazole sodium enteric-coated pellets-type tablets].
    Chen MM; Wang CR; Jin Y
    Yao Xue Xue Bao; 2011 Jan; 46(1):96-101. PubMed ID: 21465814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preparation of capsaicin-chitosan microspheres (CCMS) enteric coated tablets.
    Chen J; Huang GD; Tan SR; Guo J; Su ZQ
    Int J Mol Sci; 2013 Dec; 14(12):24305-19. PubMed ID: 24351818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic drug release from film-coated tablets.
    Ofori-Kwakye K; Fell JT
    Int J Pharm; 2003 Jan; 250(2):431-40. PubMed ID: 12527169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of a hot-melt subcoating and an enteric coating for moisture protection of hygroscopic Sennae fructus tablets.
    Zier KI; Schultze W; Leopold CS
    Pharm Dev Technol; 2019 Dec; 24(10):1210-1217. PubMed ID: 31354006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel electrostatic dry coating process for enteric coating of tablets with Eudragit® L 100-55.
    Qiao M; Zhang L; Ma Y; Zhu J; Xiao W
    Eur J Pharm Biopharm; 2013 Feb; 83(2):293-300. PubMed ID: 23183445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion of a freely water-soluble drug in aqueous enteric-coated pellets.
    Guo HX; Heinämäki J; Yliruusi J
    AAPS PharmSciTech; 2002; 3(2):E16. PubMed ID: 12916953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine.
    Liu F; Lizio R; Meier C; Petereit HU; Blakey P; Basit AW
    J Control Release; 2009 Jan; 133(2):119-24. PubMed ID: 18930772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.
    Miller DA; Gamba M; Sauer D; Purvis TP; Clemens NT; Williams RO
    Int J Pharm; 2007 Feb; 330(1-2):61-72. PubMed ID: 17034967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of enteric-coated tablets and pellets by two in vitro dissolution methods and by scanning electron microscopy.
    Odegårdstuen LI; Bjerknes K; Sande SA; Waaler T
    Acta Pharm Nord; 1991; 3(3):163-70. PubMed ID: 1793511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of poly(styrene-alt-maleic anhydride)-ethanol as enteric coating material.
    Lai X; Sun C; Tian H; Zhao W; Gao L
    Int J Pharm; 2008 Mar; 352(1-2):66-73. PubMed ID: 18054184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a multiple-unit tablet containing enteric-coated pellets.
    Dreu R; Ilić I; Srčič S
    Pharm Dev Technol; 2011 Apr; 16(2):118-26. PubMed ID: 20088675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of enteric coated tablets of proton pump inhibitor.
    Nair AB; Gupta R; Kumria R; Jacob S; Attimarad M
    J Basic Clin Pharm; 2010 Sep; 1(4):215-21. PubMed ID: 24825991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
    Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
    Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.